NO20044502L - Analgesisk oral sammensetning med kontrollert frigjoring av et opioid - Google Patents
Analgesisk oral sammensetning med kontrollert frigjoring av et opioidInfo
- Publication number
- NO20044502L NO20044502L NO20044502A NO20044502A NO20044502L NO 20044502 L NO20044502 L NO 20044502L NO 20044502 A NO20044502 A NO 20044502A NO 20044502 A NO20044502 A NO 20044502A NO 20044502 L NO20044502 L NO 20044502L
- Authority
- NO
- Norway
- Prior art keywords
- controlled release
- opioid
- oral composition
- vinylpyrrolide
- ester
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000013270 controlled release Methods 0.000 title abstract 2
- 230000000202 analgesic effect Effects 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- MZNSQRLUUXWLSB-UHFFFAOYSA-N 2-ethenyl-1h-pyrrole Chemical compound C=CC1=CC=CN1 MZNSQRLUUXWLSB-UHFFFAOYSA-N 0.000 abstract 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 abstract 2
- 235000021357 Behenic acid Nutrition 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 229940116226 behenic acid Drugs 0.000 abstract 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- RBOXVHNMENFORY-DNJOTXNNSA-N dihydrocodeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC RBOXVHNMENFORY-DNJOTXNNSA-N 0.000 abstract 1
- 229960000920 dihydrocodeine Drugs 0.000 abstract 1
- XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000001530 fumaric acid Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
Det beskrives en formulering og en fremgangsmåte for fremstilling av en fast peroral terapeutisk sammensetning med kontrollert frigjøring av virkestoffet som inneholder dihydrokodein og dets farmasøytisk akseptable salter i en nødvendig mengde, sammen med mikronisert ester av glycerol med behensyre, kalsiumfosfatdihydrat, en kopolymer av vinylpyrrolidon og vinylacetat og med natriumsaltet av esteren av fumarsyre og stearylalkohol.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SK501-2002A SK286107B6 (sk) | 2002-04-12 | 2002-04-12 | Analgeticky účinný perorálny liečivý prípravok s kontrolovaným uvoľňovaním opioidnej účinnej látky a spôsob jeho prípravy |
PCT/SK2003/000008 WO2003086365A1 (en) | 2002-04-12 | 2003-04-10 | Analgesical oral composition with controlled release of an opioid |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20044502L true NO20044502L (no) | 2004-10-26 |
Family
ID=29247067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20044502A NO20044502L (no) | 2002-04-12 | 2004-10-21 | Analgesisk oral sammensetning med kontrollert frigjoring av et opioid |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1494656B1 (no) |
AT (1) | ATE398446T1 (no) |
AU (1) | AU2003219641A1 (no) |
CZ (1) | CZ20041054A3 (no) |
DE (1) | DE60321672D1 (no) |
EA (1) | EA006846B1 (no) |
GE (1) | GEP20063991B (no) |
HU (1) | HUP0500438A3 (no) |
NO (1) | NO20044502L (no) |
PL (1) | PL372698A1 (no) |
SK (1) | SK286107B6 (no) |
UA (1) | UA74991C2 (no) |
WO (1) | WO2003086365A1 (no) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE107857T1 (de) * | 1986-06-10 | 1994-07-15 | Euro Celtique Sa | Zusammensetzung mit kontrollierter freisetzung von dihydrocodein. |
FR2753904B1 (fr) * | 1996-10-01 | 1998-10-30 | Gattefosse Ets Sa | Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication |
DE19747261A1 (de) * | 1997-10-25 | 1999-04-29 | Bayer Ag | Osmotisches Arzneimittelfreisetzungssystem |
ES2374717T3 (es) * | 1999-10-29 | 2012-02-21 | Euro-Celtique S.A. | Formulaciones de hidrocodona de liberación controlada. |
SK285128B6 (sk) * | 1999-12-28 | 2006-07-07 | Zentiva, A. S. | Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy |
-
2002
- 2002-04-12 SK SK501-2002A patent/SK286107B6/sk not_active IP Right Cessation
-
2003
- 2003-04-10 CZ CZ20041054A patent/CZ20041054A3/cs unknown
- 2003-04-10 DE DE60321672T patent/DE60321672D1/de not_active Expired - Fee Related
- 2003-04-10 PL PL03372698A patent/PL372698A1/xx not_active Application Discontinuation
- 2003-04-10 AU AU2003219641A patent/AU2003219641A1/en not_active Abandoned
- 2003-04-10 WO PCT/SK2003/000008 patent/WO2003086365A1/en not_active Application Discontinuation
- 2003-04-10 HU HU0500438A patent/HUP0500438A3/hu unknown
- 2003-04-10 AT AT03715908T patent/ATE398446T1/de not_active IP Right Cessation
- 2003-04-10 GE GEAP8496A patent/GEP20063991B/en unknown
- 2003-04-10 EA EA200401357A patent/EA006846B1/ru not_active IP Right Cessation
- 2003-04-10 EP EP03715908A patent/EP1494656B1/en not_active Expired - Lifetime
- 2003-10-04 UA UA20041109250A patent/UA74991C2/uk unknown
-
2004
- 2004-10-21 NO NO20044502A patent/NO20044502L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0500438A2 (hu) | 2005-08-29 |
AU2003219641A1 (en) | 2003-10-27 |
EP1494656B1 (en) | 2008-06-18 |
EA200401357A1 (ru) | 2005-04-28 |
SK5012002A3 (en) | 2003-11-04 |
WO2003086365A1 (en) | 2003-10-23 |
HUP0500438A3 (en) | 2008-03-28 |
SK286107B6 (sk) | 2008-03-05 |
UA74991C2 (en) | 2006-02-15 |
EA006846B1 (ru) | 2006-04-28 |
DE60321672D1 (de) | 2008-07-31 |
ATE398446T1 (de) | 2008-07-15 |
PL372698A1 (en) | 2005-07-25 |
GEP20063991B (en) | 2006-12-11 |
CZ20041054A3 (cs) | 2005-01-12 |
EP1494656A1 (en) | 2005-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2582150C (en) | Modified release ibuprofen dosage form | |
NO20065638L (no) | Formuleringer med kontrollert frigivelse inneholdende vardenafil | |
NO20080827L (no) | Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon | |
ME00325B (me) | Oblik za oralnu primjenu etilestra 3-[(2-{[4-(heksiloksikarbonjlaminoimino-metil)-fenilamino]-metil}-1-metil-ih-benzimidazol-5-carbonil)-piridin- 2-yl-amino]-propionsk kisjeline i njihovih soli | |
HRP20050077B1 (hr) | Postupci i oblici doziranja za kontrolirano oslobađanje paliperidona | |
ES2642788T3 (es) | Fabricación de gránulos sin principio activo y de comprimidos que comprenden los mismos | |
BRPI0608505A2 (pt) | comprimido sublingual revestido | |
MX2007006635A (es) | Formulacion farmaceutica de inhibidores dela carboxamida vih integrasa que contienen una composicion que controla la velocidad de liberacion. | |
CA2503361A1 (en) | Controlled-release compositions | |
BR112020003380A2 (pt) | formulações farmacêuticas para o tratamento de endometriose, miomas uterinos, síndrome do ovário policístico ou adenomiose | |
AP2003002763A0 (en) | Controlled release formulations for oral administration | |
US20090214442A1 (en) | Oral Transmucosal Nicotine Dosage Form | |
AU2018285927B2 (en) | Modified-release tiopronin compositions, kits and methods for treating cystinuria and related disorders | |
ES2652266T3 (es) | Composición sólida de dosificación oral de ibuprofeno que comprende un copolímero de ácido metacrílico | |
RS20050796A (en) | Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent | |
NO20044502L (no) | Analgesisk oral sammensetning med kontrollert frigjoring av et opioid | |
US20240066028A1 (en) | Compositions for improved delivery of cgrp inhibitors | |
WO2000026185A3 (en) | Omeprazole solution and method of using same | |
RS20060413A (en) | Non-disintegrating oral solid composition of high dose of water soluble drugs | |
JP2009507850A5 (no) | ||
JP2018012693A (ja) | ロキソプロフェン又はその塩及びビタミンeを含有する経口用医薬組成物 | |
EP2848260B1 (en) | Novel formulations of thiocolchicoside | |
TWI589292B (zh) | 用於控管噁心及嘔吐之組合物 | |
WO2011067663A1 (en) | Pharmaceutical preparations comprising phloroglucinol and/or derivatives thereof and some non-steroidal anti-inflammatory drugs and their use in the treatment and/or prevention of pain syndromes of the feminine genital system | |
JP2022501407A (ja) | ゾルピデム又はその薬学的に許容される塩の口腔粘膜溶液剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |